Literature DB >> 813180

The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.

R E Stevenson, R R Howell, V A McKusick, R Suskind, J W Hanson, D E Elliott, E F Neufeld.   

Abstract

Hurler and Scheie syndromes, two of the six clinically distinct mucopolysaccharidoses, are deficient in the same lysosomal enzyme, alpha-L-iduronidase. A third group of iduronidase-deficient patients can now be identified during the pediatric years using clinical and radiographic criteria. Based on inferential evidence for allelism between the Hurler and Scheie genes, the occurrence of genetic compounds which simultaneously carry both mutant alleles may be predicted to occur. This can be considered analogous to the structural gene mutations leading to hemoglobin SC disease. Four patients with phenotypes intermediate between Hurler and Scheie syndromes are flet to represent genetic compounds of this type. Both clinical and roentgenographic features are helpful in distinguishing these patients from those with Hurler syndrome or Scheie syndrome. Fibroblast correction characteristics identical to those of Hurler syndrome and Scheie syndrome and absence of consanguinity are additional features which favor classification as genetic compounds. The possibility of a third mutant allele at the Hurler-Scheie locus or of extreme phenotype variation are not considered likely alternative explantations. Depending on the frequency of the Scheie syndrome and the Hurler syndrome, genetic compounds may occur with an intermediate frequency or may be more common than either homozygous condition.

Entities:  

Mesh:

Year:  1976        PMID: 813180

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Acute myelogenous leukaemia in Hurler's syndrome.

Authors:  K T Chen; R W McKenna; R J Desnick
Journal:  J Med Genet       Date:  1978-06       Impact factor: 6.318

2.  Genetic heterogeneity within the chondroitinsulphaturias.

Authors:  B S Danes; B K Rottell; L Eviatar; J Stolzenberg
Journal:  J Med Genet       Date:  1977-04       Impact factor: 6.318

3.  The mucopolysaccharidoses: biochemistry and clinical symptoms.

Authors:  H Kresse; M Cantz; K von Figura; J Glössl; E Paschke
Journal:  Klin Wochenschr       Date:  1981-08-17

4.  Radiological findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome).

Authors:  H Schmidt; K Ullrich; H J von Lengerke; M Kleine; J Brämswig
Journal:  Pediatr Radiol       Date:  1987

5.  Differences in maxillomandibular morphology among patients with mucopolysaccharidoses I, II, III, IV and VI: a retrospective MRI study.

Authors:  Till Koehne; Anja Köhn; Reinhard E Friedrich; Uwe Kordes; Thorsten Schinke; Nicole Muschol; Bärbel Kahl-Nieke
Journal:  Clin Oral Investig       Date:  2017-10-18       Impact factor: 3.573

6.  Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.

Authors:  Janet A Thomas; Michael Beck; Joe T R Clarke; Gerald F Cox
Journal:  J Inherit Metab Dis       Date:  2010-06-02       Impact factor: 4.982

7.  Biliary disease in metachromatic leukodystrophy.

Authors:  L Heier; A Daneman; J A Lowden; E Cutz; S Craw; D J Martin
Journal:  Pediatr Radiol       Date:  1983

8.  Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy.

Authors:  Ramin Sedaghat Herati; Van W Knox; Patricia O'Donnell; Marina D'Angelo; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2008-08-15       Impact factor: 4.797

9.  Hybridization studies of fibroblasts from Hurler, Scheie, and Hurler/Scheie compound patients: support for the hypothesis of allelic mutants.

Authors:  J J Fortuin; W J Kleijer
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

10.  Animal model studies of allelism: characterization of arylsulfatase B mutations in homoallelic and heteroallelic (genetic compound) homozygotes with feline mucopolysaccharidosis VI.

Authors:  M M McGovern; N Mandell; M Haskins; R J Desnick
Journal:  Genetics       Date:  1985-08       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.